🔎 Trials Near Me

Akèy › Kansè tiwoyid › Distrik Columbia › Washington

Etid klinik pou Kansè tiwoyid nan Washington, DC

10 etid pou Kansè tiwoyid ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 98 · Tout sèks · Mizajou Oct 5, 2026 · NCT04927416

DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
1 Month – 99 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT01247597

Studies on Tumors of the Thyroid

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
6 Months – 98 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT00001160

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 4 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT01005654

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Ap rekriteFaz 1/2
  • Georgetown University Lombardi Cancer Center, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 90 · Tout sèks · Mizajou Sep 9, 2026 · NCT03841617

Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients

Ap rekrite
  • Georgetown University, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT06853925

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

Ap rekrite
  • Lombardi Comprehensive Cancer Center, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Jan 8, 2026 · NCT06980103

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

Ap rekriteFaz 2
  • MedStar Washington Hospital Center, Washington D.C.
Laj 12 ak plis · Tout sèks · Mizajou Dec 12, 2024 · NCT05668962

Etid Kansè tiwoyid nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.